Immune escape after adoptive T cell therapy for malignant gliomas.

CONCLUSIONS: These findings suggest that the immune landscape of brain tumors are markedly different post-immunotherapy yet can still be targeted with immunotherapy.
PMID: 32788225 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - August 10, 2020 Category: Cancer & Oncology Authors: Wildes TJ, Dyson KA, Francis CP, Wummer BM, Yang C, Yegorov O, Shin D, Grippin AJ, DiVita-Dean B, Abraham RS, Pham CD, Moore G, Kuizon C, Mitchell DA, Flores CT Tags: Clin Cancer Res Source Type: research